Lanreotide Acetate

四川多瑞药业

2025-05-22

US FDA Registration No.: 041446
Indication: Acromegaly, GEP-NETs, Carcinoid Syndrome

Batch Size:6 kg  

Annual Capacity:150 kg

Status: Validation Production Complete  


Prev:

None

Next:

Tirzepatide